COMMUNIQUÉS West-GlobeNewswire

Novelion Therapeutics Announces Leadership Change
20/11/2018
Novelion General Counsel Benjamin Harshbarger Appointed as Interim Chief Executive Officer (CEO) VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), today announced [...]
electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference
20/11/2018
BASKING RIDGE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the company will be participating in the [...]
Nabriva Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
20/11/2018
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT [...]
Xtraction Services -- Revolutionary Technology, Service & Business Model -- CFN Media
20/11/2018
Seattle, WA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Plus Products Top Edibles Brand in World's Largest Cannabis Market -- CFN Media
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Cannabis Genetics Company Green Gene Research Inc
20/11/2018
VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its strategic international partner, ICC International [...]
Stryker to participate in Evercore ISI HealthCONx Conference
20/11/2018
Kalamazoo, Michigan, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts. [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
20/11/2018
Company Announcement Copenhagen, Denmark; November 20, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 7,588 shares as a consequence of the exercise of employee warrants. The increase is [...]
Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million
20/11/2018
Pratteln, Switzerland, November 20, 2018 - Earlier today, Santhera Pharmaceuticals (SIX: SANN) announced that it has entered into an agreement to acquire the option for the exclusive sub-license to the first-in-class [...]
Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolon
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase IIb study ongoing Vamorolone has the potential to become standard of care in young patients [...]
Santhera enters into agreement to acquire option from Idorsia for exclusive sub-license of first-in-class dissociative steroid vamorolone
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase 2b study ongoing Vamorolone has the potential to become standard of care in young patients [...]
Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vaccine candidate Kinoid IL-4/IL-13 for the treatment of allergies
20/11/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vaccine candidate Kinoid IL-4/IL-13 for the treatment of allergies Paris and [...]
NÉOVACS : dépôt d'un brevet en Europe et aux États-Unis pour son nouveau candidat vaccin thérapeutique dans les allergies
20/11/2018
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce le dépôt d'un brevet en Europe et aux États-Unis pour son nouveau candidat vaccin thérapeutique Kinoïde IL- 4/IL-13 dans le traitement [...]
Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
20/11/2018
NORTHVALE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
20/11/2018
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical nerve [...]
EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference
20/11/2018
LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference, taking place November [...]
Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program in Olanzapine-Induced Weight Gain
20/11/2018
Zug, Switzerland, November 20, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Shire plc: Phase I conditional clearance by the European Commission
20/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]

Pages